Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
TEVA Seeking Alpha — January 13, 2026Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Agilent Technologies, Inc. (A) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
A Seeking Alpha — January 13, 2026Agilent Technologies, Inc. (A) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
GSK plc (GSK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
GSK Seeking Alpha — January 13, 2026GSK plc (GSK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ExxonMobil to Release Fourth Quarter 2025 Financial Results — Neutral
XOM Business Wire — January 13, 2026SPRING, Texas--(BUSINESS WIRE)--Exxon Mobil Corporation (NYSE: XOM) will release its fourth quarter 2025 financial results on Friday, January 30, 2026. The company will issue a press release via Business Wire that will be available at 5:30 a.m. CT at investor.exxonmobil.com. Darren Woods, Chairman and Chief Executive Officer; Kathy Mikells, Senior Vice President and Chief Financial Officer; Neil Hansen, incoming Senior Vice President and Chief Financial Officer (effective February 1, 2026); and.
Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
TMO Seeking Alpha — January 13, 2026Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Invesco Aerospace & Defense ETF is rated Buy, driven by President Trump's proposed $1.5T defense budget and robust U.S. military actions. PPA consistently outperforms the S&P 500, with a 10-year total return of $50,790 on $10,000 invested, and strong top-10 holdings with long dividend histories. The ETF benefits from U.S. government contracts, increased defense and space spending, and a diversified, low-turnover portfolio of established industry leaders.
Is Phillips 66 Poised to Gain From a Favorable Refining Backdrop? — Positive
PSX Zacks Investment Research — January 13, 2026PSX's refining arm benefits from strong margins, with widening light-heavy spreads and cheaper heavy crude anticipated to support higher margins.
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts — Positive
ANGO BSX MDT Zacks Investment Research — January 13, 2026ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.
GSI Technology: A Speculative Buy Scaling To Profitability — Positive
GSIT Seeking Alpha — January 13, 2026GSI Technology is rated a Buy due to its revolutionary APU technology targeting edge AI markets and a healthy, debt-free balance sheet. GSIT's legacy SRAM business is rebounding, with 38–41% YoY revenue growth, while the transformative APU segment aims for H1 2026 shipments. Cornell University validated GSIT's APU as dramatically faster and 98% more energy-efficient than GPUs, positioning GSIT for significant AI cost disruption.
Apple Picks Gemini AI in Win for Google's Tensor Chip — Positive
AAPL GOOG GOOGL Bloomberg Technology — January 13, 2026Apple chooses Google AI in a multiyear deal that highlights the cost advantage of Google's tensor processing unit chips and Apple's need to improve AI offerings. Dan Ives, managing director and senior equity analyst at Wedbush, discusses the deal with Caroline Hyde and Ed Ludlow on "Bloomberg Tech.
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
CAH Seeking Alpha — January 13, 2026Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Investors flocking to gold for safety may be making a big mistake, Goldman says — Negative
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Market Watch — January 13, 2026Gold's surge over the past 12 months hasn't kept investors from seeking exposure to it in 2026 — although an investment strategy team at Goldman Sachs isn't a fan of the precious metal as a diversifier in portfolios.
BATH & BODY WORKS, INC. (NYSE: BBWI) INVESTOR ALERT Investors With Large Losses in Bath & Body Works, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights — Neutral
BBWI GlobeNewsWire — January 13, 2026NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE: BBWI) between June 4 , 202 4 and Nov em ber 1 9 , 202 5, inclusive. For more information, submit a form at Bath & Body Works, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.
Why Apple Chose Google to Power the Future of AI — Negative
AAPL GOOG GOOGL MarketBeat — January 13, 2026In the middle of January 2026, the two largest forces in mobile computing effectively called a truce in the war for artificial intelligence (AI) dominance. After months of speculation and market volatility, Apple Inc. NASDAQ: AAPL and Alphabet Inc. NASDAQ: GOOG formalized a strategic partnership to integrate Google's Gemini models into the Apple ecosystem.
Lake City Bank Parent Announces 4% Increase in Quarterly Dividend — Neutral
LKFN GlobeNewsWire — January 13, 2026WARSAW, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, announced that the Board of Directors approved a quarterly cash dividend for the first quarter of 2026 of $0.52 per share, payable February 5, 2026, to shareholders of record as of January 25, 2026. The quarterly dividend represents a 4% increase over the quarterly dividend rate of $0.50 per share paid in 2025.
Tesla Targets Europe's Value Buyers With New Long Range Model Y — Positive
TSLA Zacks Investment Research — January 13, 2026Tesla launches Model Y Standard Long Range RWD in Europe pairing long range, efficiency and lower pricing.
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook — Positive
ADMA Zacks Investment Research — January 13, 2026ADMA expects 2025 revenues of approximately $510-$511 million, raising 2026 guidance on strong Asceniv demand and margin expansion.
Can VLO Continue to Earn From Ongoing Softness in Oil Price? — Neutral
VLO Zacks Investment Research — January 13, 2026Valero stands to gain as crude prices stay soft, lifting refining margins, strengthening its balance sheet and supporting dividends and buybacks.
Ronald A. Homer Steps Down as Chair, Jair Lynch Elected as New Board Chair Ronald A. Homer Steps Down as Chair, Jair Lynch Elected as New Board Chair
Japan stocks and the related ETFs are coming off scintillating performances in 2025. They currently rank among the best performers in developed markets.